Peptides and peptidomimetics for antimicrobial drug design

Pharmaceuticals

Volumn 8, Issue 3, 2015, Pages 366-415

  Mojsoska, Biljana ^a   Jenssen, Håvard ^a  

^a ROSKILDE UNIVERSITY   (Denmark)

Author keywords

Antimicrobial peptides; Mechanism of action; Peptidomimetics

Indexed keywords

ALPHA DEFENSIN; BETA DEFENSIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CECROPIN; INDOLICIDIN; LYSOSTAPHIN; MELITTIN; MUTACIN 1140; NISIN; POLYPEPTIDE ANTIBIOTIC AGENT; THIONIN PEPTIDE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMPHIPATHICITY; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIFUNGAL ACTIVITY; ANTIPROTOZOAL ACTIVITY; CATIONICITY; CHEMICAL PHENOMENA; CLOSTRIDIUM BOTULINUM; DISULFIDE BOND; DRUG MECHANISM; DRUG POTENCY; DRUG STRUCTURE; ESCHERICHIA COLI; HUMAN; HYDROPHOBICITY; IC50; LISTERIA MONOCYTOGENES; MEMBRANE DAMAGE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PROPIONIBACTERIUM ACNES; PROTEIN SECONDARY STRUCTURE; PSEUDOMONAS AERUGINOSA; REVIEW; SALMONELLA ENTERICA SEROVAR TYPHIMURIUM; STAPHYLOCOCCUS AUREUS; STRUCTURE ACTIVITY RELATION; VIBRIO CHOLERAE;

EID: 84937921183     PISSN: None     EISSN: 14248247     Source Type: Journal    
DOI: 10.3390/ph8030366     Document Type: Review

References (311)

1. Jenssen, H.; Hamill, P.; Hancock, R.E. Peptide antimicrobial agents. Clin. Microbiol. Rev. 2006, 19, 491-511.
2. Wimley, W.C. Describing the mechanism of antimicrobial peptide action with the interfacial activity model. ACS Chem. Biol. 2010, 5, 905-917.
3. Wang, G. Database-guided discovery of potent peptides to combat hiv-1 or superbugs. Pharmaceuticals (Basel) 2013, 6, 728-758.
4. Wang, G. Structures of human host defense cathelicidin ll-37 and its smallest antimicrobial peptide kr-12 in lipid micelles. J. Biol. Chem. 2008, 283, 32637-32643.
5. Powers, J.P.; Rozek, A.; Hancock, R.E. Structure-activity relationships for the beta-hairpin cationic antimicrobial peptide polyphemusin i. Biochim. Biophys. Acta 2004, 1698, 239-250.
6. Rozek, A.; Friedrich, C.L.; Hancock, R.E. Structure of the bovine antimicrobial peptide indolicidin bound to dodecylphosphocholine and sodium dodecyl sulfate micelles. Biochemistry 2000, 39, 15765-15774.
7. Sawai, M.V.; Jia, H.P.; Liu, L.; Aseyev, V.; Wiencek, J.M.; McCray, P.B., Jr.; Ganz, T.; Kearney, W.R.; Tack, B.F. The nmr structure of human beta-defensin-2 reveals a novel alpha-helical segment. Biochemistry 2001, 40, 3810-3816.
8. Andreu, D.; Rivas, L. Animal antimicrobial peptides: An overview. Biopolymers 1998, 47, 415-433.
9. Wang, G.; Li, X.; Wang, Z. Apd2: The updated antimicrobial peptide database and its application in peptide design. Nucleic Acids Res. 2009, 37, D933-D937.
10. Steiner, H.; Hultmark, D.; Engstrom, A.; Bennich, H.; Boman, H.G. Sequence and specificity of two antibacterial proteins involved in insect immunity. Nature 1981, 292, 246-248.
11. Pasupuleti, M.; Schmidtchen, A.; Malmsten, M. Antimicrobial peptides: Key components of the innate immune system. Crit. Rev. Biotechnol. 2012, 32, 143-171.
12. Boman, H.G. Peptide antibiotics and their role in innate immunity. Ann. Rev. immunol. 1995, 13, 61-92.
13. Thomas, E.L.; Lehrer, R.I.; Rest, R.F. Human neutrophil antimicrobial activity. Rev. Infect. Dis. 1988, 10, S450-S456.
14. Selsted, M.E.; Ouellette, A.J. Mammalian defensins in the antimicrobial immune response. Nat. Immunol. 2005, 6, 551-557.
15. Skerlavaj, B.; Romeo, D.; Gennaro, R. Rapid membrane permeabilization and inhibition of vital functions of gram-negative bacteria by bactenecins. Infect. Immun. 1990, 58, 3724-3730.
16. Ganz, T.; Selsted, M.E.; Szklarek, D.; Harwig, S.S.; Daher, K.; Bainton, D.F.; Lehrer, R.I. Defensins. Natural peptide antibiotics of human neutrophils. J. Clin. Investig. 1985, 76, 1427-1435.
17. Selsted, M.E.; Harwig, S.S.; Ganz, T.; Schilling, J.W.; Lehrer, R.I. Primary structures of three human neutrophil defensins. J. Clin. Investig. 1985, 76, 1436-1439.
18. Ganz, T. Defensins: Antimicrobial peptides of innate immunity. Nature Rev. Immunol. 2003, 3, 710-720.
19. Bowdish, D.M.; Davidson, D.J.; Hancock, R.E. Immunomodulatory properties of defensins and cathelicidins. Curr. Top. Microbiol. Immunol. 2006, 306, 27-66.
20. Pazgier, M.; Hoover, D.M.; Yang, D.; Lu, W.; Lubkowski, J. Human beta-defensins. Cell. Mol. Life Sci. 2006, 63, 1294-1313.
21. Ouellette, A.J.; Selsted, M.E. Paneth cell defensins: Endogenous peptide components of intestinal host defense. FASEB J. 1996, 10, 1280-1289.
22. Date, Y.; Nakazato, M.; Shiomi, K.; Toshimori, H.; Kangawa, K.; Matsuo, H.; Matsukura, S. Localization of human neutrophil peptide (hnp) and its messenger rna in neutrophil series. Ann. Hematol. 1994, 69, 73-77.
23. Ericksen, B.; Wu, Z.; Lu, W.; Lehrer, R.I. Antibacterial activity and specificity of the six human {alpha}-defensins. Antimicrob. Agents Chemother. 2005, 49, 269-275.
24. Porter, E.M.; van Dam, E.; Valore, E.V.; Ganz, T. Broad-spectrum antimicrobial activity of human intestinal defensin 5. Infect. Immun. 1997, 65, 2396-2401.
25. Xu, Z.; Zhong, Z.; Huang, L.; Peng, L.; Wang, F.; Cen, P. High-level production of bioactive human beta-defensin-4 in escherichia coli by soluble fusion expression. Appl. Microbiol. Biotechnol. 2006, 72, 471-479.
26. Nomura, I.; Goleva, E.; Howell, M.D.; Hamid, Q.A.; Ong, P.Y.; Hall, C.F.; Darst, M.A.; Gao, B.; Boguniewicz, M.; Travers, J.B.; et al. Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes. J. Immunol. 2003, 171, 3262-3269.
27. Lehrer, R.I.; Ganz, T. Cathelicidins: A family of endogenous antimicrobial peptides. Curr. Opin. Hematol. 2002, 9, 18-22.
28. Zaiou, M.; Gallo, R.L. Cathelicidins, essential gene-encoded mammalian antibiotics. J. Mol. Med. (Berl) 2002, 80, 549-561.
29. Scocchi, M.; Pallavicini, A.; Salgaro, R.; Bociek, K.; Gennaro, R. The salmonid cathelicidins: A gene family with highly varied c-terminal antimicrobial domains. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 2009, 152, 376-381.
30. Putsep, K.; Carlsson, G.; Boman, H.G.; Andersson, M. Deficiency of antibacterial peptides in patients with morbus kostmann: An observation study. Lancet 2002, 360, 1144-1149.
31. Szyk, A.; Wu, Z.; Tucker, K.; Yang, D.; Lu, W.; Lubkowski, J. Crystal structures of human alpha-defensins hnp4, hd5, and hd6. Protein Sci. 2006, 15, 2749-2760.
32. Hoover, D.M.; Chertov, O.; Lubkowski, J. The structure of human beta-defensin-1: New insights into structural properties of beta-defensins. J. Biol. Chem. 2001, 276, 39021-39026.
33. Trabi, M.; Schirra, H.J.; Craik, D.J. Three-dimensional structure of rtd-1, a cyclic antimicrobial defensin from rhesus macaque leukocytes. Biochemistry 2001, 40, 4211-4221.
34. Falla, T.J.; Karunaratne, D.N.; Hancock, R.E.W. Mode of action of the antimicrobial peptide indolicidin. J. Biol. Chem. 1996, 271, 19298-19303.
35. Selsted, M.E.; Novotny, M.J.; Morris, W.L.; Tang, Y.Q.; Smith, W.; Cullor, J.S. Indolicidin, a novel bactericidal tridecapeptide amide from neutrophils. J. Biol. Chem. 1992, 267, 4292-4295.
36. Hsu, C.H.; Chen, C.; Jou, M.L.; Lee, A.Y.; Lin, Y.C.; Yu, Y.P.; Huang, W.T.; Wu, S.H. Structural and DNA-binding studies on the bovine antimicrobial peptide, indolicidin: Evidence for multiple conformations involved in binding to membranes and DNA. Nucleic Acids Res. 2005, 33, 4053-4064.
37. Subbalakshmi, C.; Sitaram, N. Mechanism of antimicrobial action of indolicidin. FEMS Microbiol. Lett. 1998, 160, 91-96.
38. Wu, M.; Maier, E.; Benz, R.; Hancock, R.E. Mechanism of interaction of different classes of cationic antimicrobial peptides with planar bilayers and with the cytoplasmic membrane of escherichia coli. Biochemistry 1999, 38, 7235-7242.
39. Ghosh, A.; Kar, R.K.; Jana, J.; Saha, A.; Jana, B.; Krishnamoorthy, J.; Kumar, D.; Ghosh, S.; Chatterjee, S.; Bhunia, A. Indolicidin targets duplex DNA: Structural and mechanistic insight through a combination of spectroscopy and microscopy. ChemMedChem 2014, 9, 2052-2058.
40. Ryge, T.S.; Doisy, X.; Ifrah, D.; Olsen, J.E.; Hansen, P.R. New indolicidin analogues with potent antibacterial activity. J. Pept. Res. 2004, 64, 171-185.
41. Friedrich, C.L.; Rozek, A.; Patrzykat, A.; Hancock, R.E. Structure and mechanism of action of an indolicidin peptide derivative with improved activity against gram-positive bacteria. J. Biol. Chem. 2001, 276, 24015-24022.
42. Falla, T.J.; Hancock, R.E. Improved activity of a synthetic indolicidin analog. Antimicrob. Agents Chemother. 1997, 41, 771-775.
43. Rozek, A.; Powers, J.P.; Friedrich, C.L.; Hancock, R.E. Structure-based design of an indolicidin peptide analogue with increased protease stability. Biochemistry 2003, 42, 14130-14138.
44. Selsted, M.E.; Harwig, S.S. Determination of the disulfide array in the human defensin hnp-2. A covalently cyclized peptide. J. Biol. Chem. 1989, 264, 4003-4007.
45. Tjabringa, G.S.; Rabe, K.F.; Hiemstra, P.S. The human cathelicidin ll-37: A multifunctional peptide involved in infection and inflammation in the lung. Pulm. Pharmacol. Ther. 2005, 18, 321-327.
46. Zhao, C.; Liu, L.; Lehrer, R.I. Identification of a new member of the protegrin family by cdna cloning. FEBS Lett. 1994, 346, 285-288.
47. Cole, A.M.; Waring, A.J. The role of defensins in lung biology and therapy. Am. J. Respir. Med. 2002, 1, 249-259.
48. Zasloff, M. Magainins, a class of antimicrobial peptides from xenopus skin: Isolation, characterization of two active forms, and partial cdna sequence of a precursor. Proc. Natl. Acad. Sci. USA 1987, 84, 5449-5453.
49. Steiner, H. Secondary structure of the cecropins: Antibacterial peptides from the moth hyalophora cecropia. FEBS Lett. 1982, 137, 283-287.
50. Dempsey, C.E. The actions of melittin on membranes. Biochim. Biophys. Acta 1990, 1031, 143-161.
51. Miyata, T.; Tokunaga, F.; Yoneya, T.; Yoshikawa, K.; Iwanaga, S.; Niwa, M.; Takao, T.; Shimonishi, Y. Antimicrobial peptides, isolated from horseshoe crab hemocytes, tachyplesin ii, and polyphemusins i and ii: Chemical structures and biological activity. J. Biochem. 1989, 106, 663-668.
52. Gause, G.F.; Brazhnikova, M.G. Gramicin s - origin and mode of action. Lancet 1944, 2, 715-716.
53. Gross, E.; Morell, J.L. The structure of nisin. J. Am. Chem. Soc. 1971, 93, 4634-4635.
54. Zanetti, M. Cathelicidins, multifunctional peptides of the innate immunity. J. Leukoc. Biol. 2004, 75, 39-48.
55. Gombart, A.F.; O'Kelly, J.; Saito, T.; Koeffler, H.P. Regulation of the camp gene by 1,25(oh)2d3 in various tissues. J. Steroid Biochem. Mol. Biol. 2007, 103, 552-557.
56. Gombart, A.F.; Borregaard, N.; Koeffler, H.P. Human cathelicidin antimicrobial peptide (camp) gene is a direct target of the vitamin d receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin d3. FASEB J. 2005, 19, 1067-1077.
57. Carlberg, C. Current understanding of the function of the nuclear vitamin d receptor in response to its natural and synthetic ligands. Recent Results Cancer Res. 2003, 164, 29-42.
58. Guo, C.; Rosoha, E.; Lowry, M.B.; Borregaard, N.; Gombart, A.F. Curcumin induces human cathelicidin antimicrobial peptide gene expression through a vitamin d receptor-independent pathway. J. Nutr. Biochem. 2012, 24, 754-759.
59. Barlow, P.G.; Li, Y.; Wilkinson, T.S.; Bowdish, D.M.; Lau, Y.E.; Cosseau, C.; Haslett, C.; Simpson, A.J.; Hancock, R.E.; Davidson, D.J. The human cationic host defense peptide ll-37 mediates contrasting effects on apoptotic pathways in different primary cells of the innate immune system. J. Leukoc. Biol. 2006, 80, 509-520.
60. Hase, K.; Murakami, M.; Iimura, M.; Cole, S.P.; Horibe, Y.; Ohtake, T.; Obonyo, M.; Gallo, R.L.; Eckmann, L.; Kagnoff, M.F. Expression of ll-37 by human gastric epithelial cells as a potential host defense mechanism against helicobacter pylori. Gastroenterology 2003, 125, 1613-1625.
61. Travis, S.M.; Anderson, N.N.; Forsyth, W.R.; Espiritu, C.; Conway, B.D.; Greenberg, E.P.; McCray, P.B., Jr.; Lehrer, R.I.; Welsh, M.J.; Tack, B.F. Bactericidal activity of mammalian cathelicidin-derived peptides. Infect. Immun. 2000, 68, 2748-2755.
62. Scott, M.G.; Davidson, D.J.; Gold, M.R.; Bowdish, D.; Hancock, R.E. The human antimicrobial peptide ll-37 is a multifunctional modulator of innate immune responses. J. Immunol. 2002, 169, 3883-3891.
63. Bowdish, D.M.; Davidson, D.J.; Lau, Y.E.; Lee, K.; Scott, M.G.; Hancock, R.E. Impact of ll-37 on anti-infective immunity. J. Leukoc. Biol. 2005, 77, 451-459.
64. Barlow, P.G.; Beaumont, P.E.; Cosseau, C.; Mackellar, A.; Wilkinson, T.S.; Hancock, R.E.; Haslett, C.; Govan, J.R.; Simpson, A.J.; Davidson, D.J. The human cathelicidin ll-37 preferentially promotes apoptosis of infected airway epithelium. Am. J. Respir. Cell. Mol. Biol. 2010, 43, 692-702.
65. Yu, J.; Mookherjee, N.; Wee, K.; Bowdish, D.M.; Pistolic, J.; Li, Y.; Rehaume, L.; Hancock, R.E. Host defense peptide ll-37, in synergy with inflammatory mediator il-1beta, augments immune responses by multiple pathways. J. Immunol. 2007, 179, 7684-7691.
66. Zheng, Y.; Niyonsaba, F.; Ushio, H.; Nagaoka, I.; Ikeda, S.; Okumura, K.; Ogawa, H. Cathelicidin ll-37 induces the generation of reactive oxygen species and release of human alpha-defensins from neutrophils. Br. J. Dermatol. 2007, 157, 1124-1131.
67. Bals, R.; Weiner, D.J.; Moscioni, A.D.; Meegalla, R.L.; Wilson, J.M. Augmentation of innate host defense by expression of a cathelicidin antimicrobial peptide. Infect. Immun. 1999, 67, 6084-6089.
68. Niyonsaba, F.; Iwabuchi, K.; Someya, A.; Hirata, M.; Matsuda, H.; Ogawa, H.; Nagaoka, I. A cathelicidin family of human antibacterial peptide ll-37 induces mast cell chemotaxis. Immunology 2002, 106, 20-26.
69. Nijnik, A.; Pistolic, J.; Wyatt, A.; Tam, S.; Hancock, R.E. Human cathelicidin peptide ll-37 modulates the effects of ifn-gamma on apcs. J. Immunol. 2009, 183, 5788-5798.
70. Bulet, P.; Hetru, C.; Dimarcq, J.L.; Hoffmann, D. Antimicrobial peptides in insects; structure and function. Dev. Comp. Immunol. 1999, 23, 329-344.
71. Bulet, P.; Stocklin, R. Insect antimicrobial peptides: Structures, properties and gene regulation. Protein Pept. Lett. 2005, 12, 3-11.
72. Vizioli, J.; Bulet, P.; Charlet, M.; Lowenberger, C.; Blass, C.; Muller, H.M.; Dimopoulos, G.; Hoffmann, J.; Kafatos, F.C.; Richman, A. Cloning and analysis of a cecropin gene from the malaria vector mosquito, anopheles gambiae. Insect Mol. Biol. 2000, 9, 75-84.
73. Raghuraman, H.; Chattopadhyay, A. Melittin: A membrane-active peptide with diverse functions. Biosci. Rep. 2007, 27, 189-223.
74. Schroder, E.; Lubke, K.; Lehmann, M.; Beetz, I. Haemolytic activity and action on the surface tension of aqueous solutions of synthetic melittins and their derivatives. Experientia 1971, 27, 764-765.
75. Blondelle, S.E.; Houghten, R.A. Probing the relationships between the structure and hemolytic activity of melittin with a complete set of leucine substitution analogs. Peptide Res. 1991, 4, 12-18.
76. Blondelle, S.E.; Houghten, R.A. Hemolytic and antimicrobial activities of the twenty-four individual omission analogues of melittin. Biochemistry 1991, 30, 4671-4678.
77. Cao, Y.; Yu, R.Q.; Liu, Y.; Zhou, H.X.; Song, L.L.; Qiao, D.R. Design, recombinant expression, and antibacterial activity of the cecropins-melittin hybrid antimicrobial peptides. Curr. Microbiol. 2010, 61, 169-175.
78. Ji, S.; Li, W.; Zhang, L.; Zhang, Y.; Cao, B. Cecropin a-melittin mutant with improved proteolytic stability and enhanced antimicrobial activity against bacteria and fungi associated with gastroenteritis in vitro. Biochem. Biophys. Res. Commun. 2014, 451, 650-655.
79. Marion, D.; Bakan, B.; Elmorjani, K. Plant lipid binding proteins: Properties and applications. Biotechnol. Adv. 2007, 25, 195-197.
80. Stotz, H.U.; Thomson, J.G.; Wang, Y. Plant defensins: Defense, development and application. Plant Signal. Behav. 2009, 4, 1010-1012.
81. Beintema, J.J. Structural features of plant chitinases and chitin-binding proteins. FEBS Lett. 1994, 350, 159-163.
82. Burman, R.; Gunasekera, S.; Stromstedt, A.A.; Goransson, U. Chemistry and biology of cyclotides: Circular plant peptides outside the box. J. Nat. Prod. 2014, 77, 724-736.
83. Stec, B. Plant thionins--the structural perspective. Cell. Mol. Life Sci. 2006, 63, 1370-1385.
84. Clifton, L.A.; Sanders, M.R.; Hughes, A.V.; Neylon, C.; Frazier, R.A.; Green, R.J. Lipid binding interactions of antimicrobial plant seed defence proteins: Puroindoline-a and beta-purothionin. Phys. Chem. Chem. Physics 2011, 13, 17153-17162.
85. Samuelsson, G.; Jayawardene, A.L. Isolation and characterization of viscotoxin 1-ps from viscum album l. Ssp. Austriacum (wiesb.) vollmann, growing on pinus silvestris. Acta Pharm. Suec. 1974, 11, 175-184.
86. Giudici, M.; Pascual, R.; de la Canal, L.; Pfuller, K.; Pfuller, U.; Villalain, J. Interaction of viscotoxins a3 and b with membrane model systems: Implications to their mechanism of action. Biophys. J. 2003, 85, 971-981.
87. Stec, B.; Rao, U.; Teeter, M.M. Refinement of purothionins reveals solute particles important for lattice formation and toxicity. Part 2: Structure of beta-purothionin at 1.7 a resolution. Acta Crystallogr. D Biol. Crystallogr. 1995, 51, 914-924.
88. Bruix, M.; Jimenez, M.A.; Santoro, J.; Gonzalez, C.; Colilla, F.J.; Mendez, E.; Rico, M. Solution structure of gamma 1-h and gamma 1-p thionins from barley and wheat endosperm determined by 1h-nmr: A structural motif common to toxic arthropod proteins. Biochemistry 1993, 32, 715-724.
89. Milbradt, A.G.; Kerek, F.; Moroder, L.; Renner, C. Structural characterization of hellethionins from helleborus purpurascens. Biochemistry 2003, 42, 2404-2411.
90. Cotter, P.D.; Hill, C.; Ross, R.P. Bacteriocins: Developing innate immunity for food. Nat. Rev. Microbiol. 2005, 3, 777-788.
91. Rogers, L.A. The inhibiting effect of streptococcus lactis on lactobacillus bulgaricus. J. Bacteriol. 1928, 16, 321-325.
92. Wiedemann, I.; Breukink, E.; van Kraaij, C.; Kuipers, O.P.; Bierbaum, G.; de Kruijff, B.; Sahl, H.G. Specific binding of nisin to the peptidoglycan precursor lipid ii combines pore formation and inhibition of cell wall biosynthesis for potent antibiotic activity. J. Biol. Chem. 2001, 276, 1772-1779.
93. Hasper, H.E.; de Kruijff, B.; Breukink, E. Assembly and stability of nisin-lipid ii pores. Biochemistry 2004, 43, 11567-11575.
94. Breukink, E.; Ganz, P.; de Kruijff, B.; Seelig, J. Binding of nisin z to bilayer vesicles as determined with isothermal titration calorimetry. Biochemistry 2000, 39, 10247-10254.
95. Hasper, H.E.; Kramer, N.E.; Smith, J.L.; Hillman, J.D.; Zachariah, C.; Kuipers, O.P.; de Kruijff, B.; Breukink, E. An alternative bactericidal mechanism of action for lantibiotic peptides that target lipid ii. Science 2006, 313, 1636-1637.
96. Chan, W.C.; Leyland, M.; Clark, J.; Dodd, H.M.; Lian, L.Y.; Gasson, M.J.; Bycroft, B.W.; Roberts, G.C. Structure-activity relationships in the peptide antibiotic nisin: Antibacterial activity of fragments of nisin. FEBS Lett. 1996, 390, 129-132.
97. Strother, T.; Hamers, R.J.; Smith, L.M. Covalent attachment of oligodeoxyribonucleotides to amine-modified si (001) surfaces. Nucleic Acids Res. 2000, 28, 3535-3541.
98. Hillman, J.D.; Novak, J.; Sagura, E.; Gutierrez, J.A.; Brooks, T.A.; Crowley, P.J.; Hess, M.; Azizi, A.; Leung, K.; Cvitkovitch, D.; et al. Genetic and biochemical analysis of mutacin 1140, a lantibiotic from streptococcus mutans. Infect. Immun. 1998, 66, 2743-2749.
99. Fox, J.L. Antimicrobial peptides stage a comeback. Nat. Biotechnol. 2013, 31, 379-382.
100. Chen, C.; Fan, H.; Huang, Y.; Peng, F.; Yuan, S.; Tong, Y. Recombinant lysostaphin protects mice from methicillin-resistant staphylococcus aureus pneumonia. BioMed Res. Int. 2014, 2014, 602185.
101. Hill, C.P.; Yee, J.; Selsted, M.E.; Eisenberg, D. Crystal structure of defensin hnp-3, an amphiphilic dimer: Mechanisms of membrane permeabilization. Science 1991, 251, 1481-1485.
102. Zhang, X.L.; Selsted, M.E.; Pardi, A. Nmr studies of defensin antimicrobial peptides. 1. Resonance assignment and secondary structure determination of rabbit np-2 and human hnp-1. Biochemistry 1992, 31, 11348-11356.
103. Pardi, A.; Zhang, X.L.; Selsted, M.E.; Skalicky, J.J.; Yip, P.F. Nmr studies of defensin antimicrobial peptides. 2. Three-dimensional structures of rabbit np-2 and human hnp-1. Biochemistry 1992, 31, 11357-11364.
104. De Leeuw, E.; Li, C.; Zeng, P.; Diepeveen-de Buin, M.; Lu, W.Y.; Breukink, E.; Lu, W. Functional interaction of human neutrophil peptide-1 with the cell wall precursor lipid ii. FEBS Lett. 2010, 584, 1543-1548.
105. Yeaman, M.R.; Yount, N.Y. Mechanisms of antimicrobial peptide action and resistance. Pharmacol. Rev. 2003, 55, 27-55.
106. Epand, R.M.; Shai, Y.; Segrest, J.P.; Anantharamaiah, G.M. Mechanisms for the modulation of membrane bilayer properties by amphipathic helical peptides. Biopolymers 1995, 37, 319-338.
107. Jahnsen, R.D.; Frimodt-Moller, N.; Franzyk, H. Antimicrobial activity of peptidomimetics against multidrug-resistant escherichia coli : A comparative study of different backbones. J. Med. Chem. 2012, 55, 7253-7261.
108. Epand, R.M.; Vogel, H.J. Diversity of antimicrobial peptides and their mechanisms of action. Biochim. Biophys. Acta 1999, 1462, 11-28.
109. Padmanabhan, S.; York, E.J.; Stewart, J.M.; Baldwin, R.L. Helix propensities of basic amino acids increase with the length of the side-chain. J. Mol. Biol. 1996, 257, 726-734.
110. Pace, C.N.; Scholtz, J.M. A helix propensity scale based on experimental studies of peptides and proteins. Biophys. J. 1998, 75, 422-427.
111. Deslouches, B.; Phadke, S.M.; Lazarevic, V.; Cascio, M.; Islam, K.; Montelaro, R.C.; Mietzner, T.A. De novo generation of cationic antimicrobial peptides: Influence of length and tryptophan substitution on antimicrobial activity. Antimicrob. Agents Chemother. 2005, 49, 316-322.
112. Javadpour, M.M.; Juban, M.M.; Lo, W.C.; Bishop, S.M.; Alberty, J.B.; Cowell, S.M.; Becker, C.L.; McLaughlin, M.L. De novo antimicrobial peptides with low mammalian cell toxicity. J. Med. Chem. 1996, 39, 3107-3113.
113. Rajabi, M.; de Leeuw, E.; Pazgier, M.; Li, J.; Lubkowski, J.; Lu, W. The conserved salt bridge in human alpha-defensin 5 is required for its precursor processing and proteolytic stability. J. Biol. Chem. 2008, 283, 21509-21518.
114. Hunter, H.N.; Demcoe, A.R.; Jenssen, H.; Gutteberg, T.J.; Vogel, H.J. Human lactoferricin is partially folded in aqueous solution and is better stabilized in a membrane mimetic solvent. Antimicrob. Agents Chemother. 2005, 49, 3387-3395.
115. Wommack, A.J.; Robson, S.A.; Wanniarachchi, Y.A.; Wan, A.; Turner, C.J.; Wagner, G.; Nolan, E.M. Nmr solution structure and condition-dependent oligomerization of the antimicrobial peptide human defensin 5. Biochemistry 2012, 51, 9624-9637.
116. De Leeuw, E.; Rajabi, M.; Zou, G.; Pazgier, M.; Lu, W. Selective arginines are important for the antibacterial activity and host cell interaction of human alpha-defensin 5. FEBS Lett. 2009, 583, 2507-2512.
117. Wei, G.; de Leeuw, E.; Pazgier, M.; Yuan, W.R.; Zou, G.Z.; Wang, J.F.; Ericksen, B.; Lu, W.Y.; Lehrer, R.I.; Lu, W.Y. Through the looking glass, mechanistic insights from enantiomeric human defensins. J. Biol. Chem. 2009, 284, 29180-29192.
118. Pazgier, M.; Prahl, A.; Hoover, D.M.; Lubkowski, J. Studies of the biological properties of human beta-defensin 1. J. Biol. Chem. 2007, 282, 1819-1829.
119. Harder, J.; Bartels, J.; Christophers, E.; Schroder, J.M. A peptide antibiotic from human skin. Nature 1997, 387, 861-861.
120. Schibli, D.J.; Hunter, H.N.; Aseyev, V.; Starner, T.D.; Wiencek, J.M.; McCray, P.B.; Tack, B.F.; Vogel, H.J. The solution structures of the human beta-defensins lead to a better understanding of the potent bactericidal activity of hbd3 against staphylococcus aureus. J. Biol. Chem. 2002, 277, 8279-8289.
121. Dathe, M.; Nikolenko, H.; Meyer, J.; Beyermann, M.; Bienert, M. Optimization of the antimicrobial activity of magainin peptides by modification of charge. FEBS Lett. 2001, 501, 146-150.
122. Hilpert, K.; Elliott, M.R.; Volkmer-Engert, R.; Henklein, P.; Donini, O.; Zhou, Q.; Winkler, D.F.H.; Hancock, R.E.W. Sequence requirements and an optimization strategy for short antimicrobial peptides. Chem. Biol. 2006, 13, 1101-1107.
123. Sawyer, J.G.; Martin, N.L.; Hancock, R.E.W. Interaction of macrophage cationic proteins with the outer-membrane of pseudomonas-aeruginosa. Infect. Immun. 1988, 56, 693-698.
124. Piers, K.L.; Hancock, R.E.W. The interaction of a recombinant cecropin/melittin hybrid peptide with the outer-membrane of pseudomonas-aeruginosa. Mol. Microbiol. 1994, 12, 951-958.
125. Matsuzaki, K. Control of cell selectivity of antimicrobial peptides. Biochim. Biophys. Acta 2009, 1788, 1687-1692.
126. Yin, L.M.; Edwards, M.A.; Li, J.; Yip, C.M.; Deber, C.M. Roles of hydrophobicity and charge distribution of cationic antimicrobial peptides in peptide-membrane interactions. J. Biol. Chem. 2012, 287, 7738-7745.
127. Wieprecht, T.; Dathe, M.; Krause, E.; Beyermann, M.; Maloy, W.L.; MacDonald, D.L.; Bienert, M. Modulation of membrane activity of amphipathic, antibacterial peptides by slight modifications of the hydrophobic moment. FEBS Lett. 1997, 417, 135-140.
128. Gopal, R.; Seo, C.H.; Song, P.I.; Park, Y. Effect of repetitive lysine-tryptophan motifs on the bactericidal activity of antimicrobial peptides. Amino acids 2013, 44, 645-660.
129. Eisenberg, D. Three-dimensional structure of membrane and surface proteins. Ann. Rev. Biochem. 1984, 53, 595-623.
130. Fernandez-Vidall, M.; Jayasinghe, S.; Ladokhin, A.S.; White, S.H. Folding amphipathic helices into membranes: Amphiphilicity trumps hydrophobicity. J. Mol. Biol. 2007, 370, 459-470.
131. Chen, Y.; Mant, C.T.; Farmer, S.W.; Hancock, R.E.; Vasil, M.L.; Hodges, R.S. Rational design of alpha-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index. J. Biol. Chem. 2005, 280, 12316-12329.
132. Thaker, H.D.; Cankaya, A.; Scott, R.W.; Tew, G.N. Role of amphiphilicity in the design of synthetic mimics of antimicrobial peptides with gram-negative activity. ACS Med. Chem. Lett. 2013, 4, 481-485.
133. Wessolowski, A.; Bienert, M.; Dathe, M. Antimicrobial activity of arginine- and tryptophan-rich hexapeptides: The effects of aromatic clusters, d-amino acid substitution and cyclization. J. Pept. Res. 2004, 64, 159-169.
134. Pathak, N.; Salas-Auvert, R.; Ruche, G.; Janna, M.H.; McCarthy, D.; Harrison, R.G. Comparison of the effects of hydrophobicity, amphiphilicity, and alpha-helicity on the activities of antimicrobial peptides. Proteins 1995, 22, 182-186.
135. Andreu, D.; Ubach, J.; Boman, A.; Wahlin, B.; Wade, D.; Merrifield, R.B.; Boman, H.G. Shortened cecropin a-melittin hybrids. Significant size reduction retains potent antibiotic activity. FEBS Lett. 1992, 296, 190-194.
136. Kondejewski, L.H.; Jelokhani-Niaraki, M.; Farmer, S.W.; Lix, B.; Kay, C.M.; Sykes, B.D.; Hancock, R.E.W.; Hodges, R.S. Dissociation of antimicrobial and hemolytic activities in cyclic peptide diastereomers by systematic alterations in amphipathicity. J. Biol. Chem. 1999, 274, 13181-13192.
137. Kushibiki, T.; Kamiya, M.; Aizawa, T.; Kumaki, Y.; Kikukawa, T.; Mizuguchi, M.; Demura, M.; Kawabata, S.; Kawano, K. Interaction between tachyplesin i, an antimicrobial peptide derived from horseshoe crab, and lipopolysaccharide. Biochim. Biophys. Acta 2014, 1844, 527-534.
138. Fahrner, R.L.; Dieckmann, T.; Harwig, S.S.; Lehrer, R.I.; Eisenberg, D.; Feigon, J. Solution structure of protegrin-1, a broad-spectrum antimicrobial peptide from porcine leukocytes. Chem. Biol. 1996, 3, 543-550.
139. Bagheri, M.; Keller, S.; Dathe, M. Interaction of w-substituted analogs of cyclo-rrrwfw with bacterial lipopolysaccharides: The role of the aromatic cluster in antimicrobial activity. Antimicrob. Agents Chemother. 2011, 55, 788-797.
140. Scheinpflug, K.; Nikolenko, H.; Komarov, I.V.; Rautenbach, M.; Dathe, M. What goes around comes around-a comparative study of the influence of chemical modifications on the antimicrobial properties of small cyclic peptides. Pharmaceuticals (Basel) 2013, 6, 1130-1144.
141. Kondejewski, L.H.; Farmer, S.W.; Wishart, D.S.; Hancock, R.E.; Hodges, R.S. Gramicidin s is active against both gram-positive and gram-negative bacteria. Int. J. Pept. Protein Res. 1996, 47, 460-466.
142. Kondejewski, L.H.; Farmer, S.W.; Wishart, D.S.; Kay, C.M.; Hancock, R.E.; Hodges, R.S. Modulation of structure and antibacterial and hemolytic activity by ring size in cyclic gramicidin s analogs. J. Biol. Chem. 1996, 271, 25261-25268.
143. Appelt, C.; Wessolowski, A.; Soderhall, J.A.; Dathe, M.; Schmieder, P. Structure of the antimicrobial, cationic hexapeptide cyclo(rrwwrf) and its analogues in solution and bound to detergent micelles. Chembiochem 2005, 6, 1654-1662.
144. Trabi, M.; Craik, D.J. Circular proteins--no end in sight. Trends Biochem. Sci. 2002, 27, 132-138.
145. Bionda, N.; Stawikowski, M.; Stawikowska, R.; Cudic, M.; Lopez-Vallejo, F.; Treitl, D.; Medina-Franco, J.; Cudic, P. Effects of cyclic lipodepsipeptide structural modulation on stability, antibacterial activity, and human cell toxicity. ChemMedChem 2012, 7, 871-882.
146. Liu, Z.G.; Brady, A.; Young, A.; Rasimick, B.; Chen, K.; Zhou, C.H.; Kallenbach, N.R. Length effects in antimicrobial peptides of the (rw)(n) series. Antimicrob. Agents Chemother. 2007, 51, 597-603.
147. Niidome, T.; Matsuyama, N.; Kunihara, M.; Hatakeyama, T.; Aoyagi, H. Effect of chain length of cationic model peptides on antibacterial activity. Bull. Chem. Soc. Jpn. 2005, 78, 473-476.
148. Dong, N.; Ma, Q.; Shan, A.; Lv, Y.; Hu, W.; Gu, Y.; Li, Y. Strand length-dependent antimicrobial activity and membrane-active mechanism of arginine- and valine-rich beta-hairpin-like antimicrobial peptides. Antimicrob. Agents Chemother. 2012, 56, 2994-3003.
149. Wang, G.; Mishra, B.; Epand, R.F.; Epand, R.M. High-quality 3d structures shine light on antibacterial, anti-biofilm and antiviral activities of human cathelicidin ll-37 and its fragments. Biochim. Biophys. Acta 2014, 1838, 2160-2172.
150. Shepherd, C.M.; Schaus, K.A.; Vogel, H.J.; Juffer, A.H. Molecular dynamics study of peptidebilayer adsorption. Biophys. J. 2001, 80, 579-596.
151. Aliste, M.P.; MacCallum, J.L.; Tieleman, D.P. Molecular dynamics simulations of pentapeptides at interfaces: Salt bridge and cation-pi interactions. Biochemistry 2003, 42, 8976-8987.
152. Zou, G.Z.; de Leeuw, E.; Li, C.; Pazgier, M.; Li, C.Q.; Zeng, P.Y.; Lu, W.Y.; Lubkowski, J.; Lu, W.Y. Toward understanding the cationicity of defensins. arg and lys versus their noncoded analogs. J. Biol. Chem. 2007, 282, 19653-19665.
153. Kang, J.H.; Lee, M.K.; Kim, K.L.; Hahm, K.S. Structure-biological activity relationships of 11-residue highly basic peptide segment of bovine lactoferrin. Int. J. Pept. Protein Res. 1996, 48, 357-363.
154. Gopal, R.; Park, S.C.; Ha, K.J.; Cho, S.J.; Kim, S.W.; Song, P.I.; Nah, J.W.; Park, Y.; Hahm, K.S. Effect of leucine and lysine substitution on the antimicrobial activity and evaluation of the mechanism of the hpa3nt3 analog peptide. J. Pept. Sci. 2009, 15, 589-594.
155. Mitchell, D.J.; Kim, D.T.; Steinman, L.; Fathman, C.G.; Rothbard, J.B. Polyarginine enters cells more efficiently than other polycationic homopolymers. J. Pept. Res. 2000, 56, 318-325.
156. Cordier, C.; Boutimah, F.; Bourdeloux, M.; Dupuy, F.; Met, E.; Alberti, P.; Loll, F.; Chassaing, G.; Burlina, F.; Saison-Behmoaras, T.E. Delivery of antisense peptide nucleic acids to cells by conjugation with small arginine-rich cell-penetrating peptide (r/w)9. PloS ONE 2014, 9, e104999.
157. Morita, S.; Tagai, C.; Shiraishi, T.; Miyaji, K.; Iwamuro, S. Differential mode of antimicrobial actions of arginine-rich and lysine-rich histones against gram-positive staphylococcus aureus. Peptides 2013, 48, 75-82.
158. Kawasaki, H.; Koyama, T.; Conlon, J.M.; Yamakura, F.; Iwamuro, S. Antimicrobial action of histone h2b in escherichia coli: Evidence for membrane translocation and DNA-binding of a histone h2b fragment after proteolytic cleavage by outer membrane proteinase t. Biochimie 2008, 90, 1693-1702.
159. Tagai, C.; Morita, S.; Shiraishi, T.; Miyaji, K.; Iwamuro, S. Antimicrobial properties of arginineand lysine-rich histones and involvement of bacterial outer membrane protease t in their differential mode of actions. Peptides 2011, 32, 2003-2009.
160. Li, X.; Saravanan, R.; Kwak, S.K.; Leong, S.S.J. Biomolecular engineering of a human beta defensin model for increased salt resistance. Chem. Eng. Sci. 2013, 95, 128-137.
161. Scudiero, O.; Galdiero, S.; Cantisani, M.; Di Noto, R.; Vitiello, M.; Galdiero, M.; Naclerio, G.; Cassiman, J.J.; Pedone, C.; Castaldo, G.; et al. Novel synthetic, salt-resistant analogs of human beta-defensins 1 and 3 endowed with enhanced antimicrobial activity. Antimicrob. Agents Chemother. 2010, 54, 2312-2322.
162. Liu, Z.; Young, A.W.; Hu, P.; Rice, A.J.; Zhou, C.; Zhang, Y.; Kallenbach, N.R. Tuning the membrane selectivity of antimicrobial peptides by using multivalent design. Chembiochem 2007, 8, 2063-2065.
163. Nakase, I.; Okumura, S.; Katayama, S.; Hirose, H.; Pujals, S.; Yamaguchi, H.; Arakawa, S.; Shimizu, S.; Futaki, S. Transformation of an antimicrobial peptide into a plasma membrane-permeable, mitochondria-targeted peptide via the substitution of lysine with arginine. Chem. Commun. (Camb) 2012, 48, 11097-11099.
164. Vogel, H.J.; Schibli, D.J.; Jing, W.; Lohmeier-Vogel, E.M.; Epand, R.F.; Epand, R.M. Towards a structure-function analysis of bovine lactoferricin and related tryptophan- and arginine-containing peptides. Biochem. Cell Biol. 2002, 80, 49-63.
165. Khandelia, H.; Kaznessis, Y.N. Cation-pi interactions stabilize the structure of the antimicrobial peptide indolicidin near membranes: Molecular dynamics simulations. J. Phys. Chemi. B 2007, 111, 242-250.
166. Bi, X.; Wang, C.; Dong, W.; Zhu, W.; Shang, D. Antimicrobial properties and interaction of two trp-substituted cationic antimicrobial peptides with a lipid bilayer. J. Antibiot. 2014, 67, 361-368.
167. Yau, W.M.; Wimley, W.C.; Gawrisch, K.; White, S.H. The preference of tryptophan for membrane interfaces. Biochemistry 1998, 37, 14713-14718.
168. Shepherd, C.M.; Vogel, H.J.; Tieleman, D.P. Interactions of the designed antimicrobial peptide mb21 and truncated dermaseptin s3 with lipid bilayers: Molecular-dynamics simulations. Biochem. J. 2003, 370, 233-243.
169. Bi, X.; Wang, C.; Ma, L.; Sun, Y.; Shang, D. Investigation of the role of tryptophan residues in cationic antimicrobial peptides to determine the mechanism of antimicrobial action. J. Appl. Microbiol. 2013, 115, 663-672.
170. Tanabe, H.; Ayabe, T.; Maemoto, A.; Ishikawa, C.; Inaba, Y.; Sato, R.; Moriichi, K.; Okamoto, K.; Watari, J.; Kono, T.; et al. Denatured human alpha-defensin attenuates the bactericidal activity and the stability against enzymatic digestion. Biochem. Biophys. Res. Commun. 2007, 358, 349-355.
171. Miles, K.; Clarke, D.J.; Lu, W.; Sibinska, Z.; Beaumont, P.E.; Davidson, D.J.; Barr, T.A.; Campopiano, D.J.; Gray, M. Dying and necrotic neutrophils are anti-inflammatory secondary to the release of alpha-defensins. J. Immunol. 2009, 183, 2122-2132.
172. Varkey, J.; Nagaraj, R. Antibacterial activity of human neutrophil defensin hnp-1 analogs without cysteines. Antimicrob. Agents Chemother. 2005, 49, 4561-4566.
173. Kluver, E.; Schulz-Maronde, S.; Scheid, S.; Meyer, B.; Forssmann, W.G.; Adermann, K. Structure-activity relation of human beta-defensin 3: Influence of disulfide bonds and cysteine substitution on antimicrobial activity and cytotoxicity. Biochemistry 2005, 44, 9804-9816.
174. Zhang, L.; Scott, M.G.; Yan, H.; Mayer, L.D.; Hancock, R.E. Interaction of polyphemusin i and structural analogs with bacterial membranes, lipopolysaccharide, and lipid monolayers. Biochemistry 2000, 39, 14504-14514.
175. Ostberg, N.; Kaznessis, Y. Protegrin structure-activity relationships: Using homology models of synthetic sequences to determine structural characteristics important for activity. Peptides 2005, 26, 197-206.
176. Gottler, L.M.; de la Salud Bea, R.; Shelburne, C.E.; Ramamoorthy, A.; Marsh, E.N. Using fluorous amino acids to probe the effects of changing hydrophobicity on the physical and biological properties of the beta-hairpin antimicrobial peptide protegrin-1. Biochemistry 2008, 47, 9243-9250.
177. Chen, J.; Falla, T.J.; Liu, H.; Hurst, M.A.; Fujii, C.A.; Mosca, D.A.; Embree, J.R.; Loury, D.J.; Radel, P.A.; Cheng Chang, C.; et al. Development of protegrins for the treatment and prevention of oral mucositis: Structure-activity relationships of synthetic protegrin analogues. Biopolymers 2000, 55, 88-98.
178. Mangoni, M.E.; Aumelas, A.; Charnet, P.; Roumestand, C.; Chiche, L.; Despaux, E.; Grassy, G.; Calas, B.; Chavanieu, A. Change in membrane permeability induced by protegrin 1: Implication of disulphide bridges for pore formation. FEBS Lett. 1996, 383, 93-98.
179. Harwig, S.S.; Waring, A.; Yang, H.J.; Cho, Y.; Tan, L.; Lehrer, R.I. Intramolecular disulfide bonds enhance the antimicrobial and lytic activities of protegrins at physiological sodium chloride concentrations. Eur. J. Biochem. 1996, 240, 352-357.
180. Lazaridis, T.; He, Y.; Prieto, L. Membrane interactions and pore formation by the antimicrobial peptide protegrin. Biophys. J. 2013, 104, 633-642.
181. Mani, R.; Cady, S.D.; Tang, M.; Waring, A.J.; Lehrert, R.I.; Hong, M. Membrane-dependent oligomeric structure and pore formation of beta-hairpin antimicrobial peptide in lipid bilayers from solid-state nmr. Proc. Natl. Acad. Sci. USA 2006, 103, 16242-16247.
182. Aumelas, A.; Mangoni, M.; Roumestand, C.; Chiche, L.; Despaux, E.; Grassy, G.; Calas, B.; Chavanieu, A. Synthesis and solution structure of the antimicrobial peptide protegrin-1. Eur. J. Biochem. 1996, 237, 575-583.
183. Mohanram, H.; Bhattacharjya, S. Cysteine deleted protegrin-1 (cdp-1): Anti-bacterial activity, outer-membrane disruption and selectivity. Biochim. Biophys. Acta 2014, 1840, 3006-3016.
184. Mosca, D.A.; Hurst, M.A.; So, W.; Viajar, B.S.; Fujii, C.A.; Falla, T.J. Ib-367, a protegrin peptide with in vitro and in vivo activities against the microflora associated with oral mucositis. Antimicrob. Agents Chemother. 2000, 44, 1803-1808.
185. Trotti, A.; Garden, A.; Warde, P.; Symonds, P.; Langer, C.; Redman, R.; Pajak, T.F.; Fleming, T.R.; Henke, M.; Bourhis, J.; et al. A multinational, randomized phase iii trial of iseganan hcl oral solution for reducing the severity of oral mucositis in patients receiving radiotherapy for head-andneck malignancy. Int. J. Radiat. Oncol. Biol. Phys. 2004, 58, 674-681.
186. Scocchi, M.; Tossi, A.; Gennaro, R. Proline-rich antimicrobial peptides: Converging to a non-lytic mechanism of action. Cell. Mol. Life Sci. 2011, 68, 2317-2330.
187. Podda, E.; Benincasa, M.; Pacor, S.; Micali, F.; Mattiuzzo, M.; Gennaro, R.; Scocchi, M. Dual mode of action of bac7, a proline-rich antibacterial peptide. Biochim. Biophys. Acta 2006, 1760, 1732-1740.
188. Boman, H.G.; Agerberth, B.; Boman, A. Mechanisms of action on escherichia coli of cecropin p1 and pr-39, two antibacterial peptides from pig intestine. Infect. Immun. 1993, 61, 2978-2984.
189. Cabiaux, V.; Agerberth, B.; Johansson, J.; Homble, F.; Goormaghtigh, E.; Ruysschaert, J.M. Secondary structure and membrane interaction of pr-39, a pro+arg-rich antibacterial peptide. Eur. J. Biochem. 1994, 224, 1019-1027.
190. Taguchi, S.; Mita, K.; Ichinohe, K.; Hashimoto, S. Targeted engineering of the antibacterial peptide apidaecin, based on an in vivo monitoring assay system. Appl. Environ. Microbiol. 2009, 75, 1460-1464.
191. Casteels, P.; Ampe, C.; Jacobs, F.; Vaeck, M.; Tempst, P. Apidaecins: Antibacterial peptides from honeybees. EMBO J. 1989, 8, 2387-2391.
192. Bulet, P.; Urge, L.; Ohresser, S.; Hetru, C.; Otvos, L., Jr. Enlarged scale chemical synthesis and range of activity of drosocin, an o-glycosylated antibacterial peptide of drosophila. Eur. J. Biochem. 1996, 238, 64-69.
193. Kragol, G.; Hoffmann, R.; Chattergoon, M.A.; Lovas, S.; Cudic, M.; Bulet, P.; Condie, B.A.; Rosengren, K.J.; Montaner, L.J.; Otvos, L., Jr. Identification of crucial residues for the antibacterial activity of the proline-rich peptide, pyrrhocoricin. Eur. J. Biochem. 2002, 269, 4226-4237.
194. Cociancich, S.; Dupont, A.; Hegy, G.; Lanot, R.; Holder, F.; Hetru, C.; Hoffmann, J.A.; Bulet, P. Novel inducible antibacterial peptides from a hemipteran insect, the sap-sucking bug pyrrhocoris apterus. Biochem. J. 1994, 300(Pt 2), 567-575.
195. Otvos, L., Jr.; Bokonyi, K.; Varga, I.; Otvos, B.I.; Hoffmann, R.; Ertl, H.C.; Wade, J.D.; McManus, A.M.; Craik, D.J.; Bulet, P. Insect peptides with improved protease-resistance protect mice against bacterial infection. Protein Sci. 2000, 9, 742-749.
196. Otvos, L.; Snyder, C.; Condie, B.; Bulet, P.; Wade, J.D. Chimeric antimicrobial peptides exhibit multiple modes of action. Int. J. Pept. Res. Ther. 2005, 11, 29-42.
197. Casteels, P.; Tempst, P. Apidaecin-type peptide antibiotics function through a non-poreforming mechanism involving stereospecificity. Biochem. Biophys. Res. Commun. 1994, 199, 339-345.
198. Fernandez-Carneado, J.; Kogan, M.J.; Castel, S.; Giralt, E. Potential peptide carriers: Amphipathic proline-rich peptides derived from the n-terminal domain of gamma-zein. Angew. Chem. Int. Ed. Engl. 2004, 43, 1811-1814.
199. Cassone, M.; Vogiatzi, P.; La Montagna, R.; De Olivier Inacio, V.; Cudic, P.; Wade, J.D.; Otvos, L., Jr. Scope and limitations of the designer proline-rich antibacterial peptide dimer, a3-apo, alone or in synergy with conventional antibiotics. Peptides 2008, 29, 1878-1886.
200. Stensvag, K.; Haug, T.; Sperstad, S.V.; Rekdal, O.; Indrevoll, B.; Styrvold, O.B. Arasin 1, a proline-arginine-rich antimicrobial peptide isolated from the spider crab, hyas araneus. Dev. Comp. Immunol. 2008, 32, 275-285.
201. Paulsen, V.S.; Blencke, H.M.; Benincasa, M.; Haug, T.; Eksteen, J.J.; Styrvold, O.B.; Scocchi, M.; Stensvag, K. Structure-activity relationships of the antimicrobial peptide arasin 1 - and mode of action studies of the n-terminal, proline-rich region. PloS ONE 2013, 8, e53326.
202. Kragol, G.; Lovas, S.; Varadi, G.; Condie, B.A.; Hoffmann, R.; Otvos, L., Jr. The antibacterial peptide pyrrhocoricin inhibits the atpase actions of dnak and prevents chaperone-assisted protein folding. Biochemistry 2001, 40, 3016-3026.
203. Crespo, L.; Sanclimens, G.; Montaner, B.; Perez-Tomas, R.; Royo, M.; Pons, M.; Albericio, F.; Giralt, E. Peptide dendrimers based on polyproline helices. J. Am. Chem. Soc. 2002, 124, 8876-8883.
204. Rozgonyi, F.; Szabo, D.; Kocsis, B.; Ostorhazi, E.; Abbadessa, G.; Cassone, M.; Wade, J.D.; Otvos, L., Jr. The antibacterial effect of a proline-rich antibacterial peptide a3-apo. Curr. Med. Chem. 2009, 16, 3996-4002.
205. Shen, X.; Ye, G.; Cheng, X.; Yu, C.; Altosaar, I.; Hu, C. Characterization of an abaecin-like antimicrobial peptide identified from a pteromalus puparum cdna clone. J. Invertebr. Pathol. 2010, 105, 24-29.
206. Schneider, M.; Dorn, A. Differential infectivity of two pseudomonas species and the immune response in the milkweed bug, oncopeltus fasciatus (insecta: Hemiptera). J. Invertebr. Pathol. 2001, 78, 135-140.
207. Fritsche, S.; Knappe, D.; Berthold, N.; von Buttlar, H.; Hoffmann, R.; Alber, G. Absence of in vitro innate immunomodulation by insect-derived short proline-rich antimicrobial peptides points to direct antibacterial action in vivo. J. Pept. Sci. 2012, 18, 599-608.
208. Krizsan, A.; Volke, D.; Weinert, S.; Strater, N.; Knappe, D.; Hoffmann, R. Insect-derived prolinerich antimicrobial peptides kill bacteria by inhibiting bacterial protein translation at the 70 s ribosome. Angew. Chem. Int. Ed. Engl. 2014, 53, 12236-12239.
209. Bobone, S.; Roversi, D.; Giordano, L.; De Zotti, M.; Formaggio, F.; Toniolo, C.; Park, Y.; Stella, L. The lipid dependence of antimicrobial peptide activity is an unreliable experimental test for different pore models. Biochemistry 2012, 51, 10124-10126.
210. Roversi, D.; Luca, V.; Aureli, S.; Park, Y.; Mangoni, M.L.; Stella, L. How many antimicrobial peptide molecules kill a bacterium? The case of pmap-23. ACS Chem. Biol. 2014, 9, 2003-2007.
211. Huang, H.W. Action of antimicrobial peptides: Two-state model. Biochemistry 2000, 39, 8347-8352.
212. Andrushchenko, V.V.; Aarabi, M.H.; Nguyen, L.T.; Prenner, E.J.; Vogel, H.J. Thermodynamics of the interactions of tryptophan-rich cathelicidin antimicrobial peptides with model and natural membranes. Biochim. Biophys. Acta 2008, 1778, 1004-1014.
213. Zasloff, M. Antimicrobial peptides of multicellular organisms. Nature 2002, 415, 389-395.
214. Kagan, B.L.; Selsted, M.E.; Ganz, T.; Lehrer, R.I. Antimicrobial defensin peptides form voltage-dependent ion-permeable channels in planar lipid bilayer membranes. Proc. Natl. Acad. Sci. USA 1990, 87, 210-214.
215. Papo, N.; Shai, Y. A molecular mechanism for lipopolysaccharide protection of gram-negative bacteria from antimicrobial peptides. J. Biol. Chem. 2005, 280, 10378-10387.
216. Andra, J.; Gutsmann, T.; Garidel, P.; Brandenburg, K. Mechanisms of endotoxin neutralization by synthetic cationic compounds. J. Endotoxin Res. 2006, 12, 261-277.
217. Bobone, S.; Gerelli, Y.; De Zotti, M.; Bocchinfuso, G.; Farrotti, A.; Orioni, B.; Sebastiani, F.; Latter, E.; Penfold, J.; Senesi, R.; et al. Membrane thickness and the mechanism of action of the short peptaibol trichogin ga iv. Biochim. Biophys. Acta Biomembr. 2013, 1828, 1013-1024.
218. Kourie, J.I.; Shorthouse, A.A. Properties of cytotoxic peptide-formed ion channels. Am. J. Physiol. Cell. Physiol. 2000, 278, C1063-C1087.
219. Tarao, K.; Shimizu, A.; Ohkawa, S.; Harada, M.; Ito, Y.; Tamai, S.; Kuni, Y.; Nagaoka, T.; Hoshino, H. Increased uptake of bromodeoxyuridine by hepatocytes from early stage of primary biliary-cirrhosis. Gastroenterology 1991, 100, 725-730.
220. Steiner, H.; Andreu, D.; Merrifield, R.B. Binding and action of cecropin and cecropin analogues: Antibacterial peptides from insects. Biochim. Biophys. Acta 1988, 939, 260-266.
221. Lichtenstein, A. Mechanism of mammalian cell lysis mediated by peptide defensins. Evidence for an initial alteration of the plasma membrane. J. Clin. Investig. 1991, 88, 93-100.
222. Lehrer, R.I.; Barton, A.; Daher, K.A.; Harwig, S.S.; Ganz, T.; Selsted, M.E. Interaction of human defensins with escherichia coli. Mechanism of bactericidal activity. J. Clin. Investig. 1989, 84, 553-561.
223. Ehrenstein, G.; Lecar, H. Electrically gated ionic channels in lipid bilayers. Q. Rev. Biophys. 1977, 10, 1-34.
224. Brogden, K.A. Antimicrobial peptides: Pore formers or metabolic inhibitors in bacteria? Nat. Rev. Microbiol. 2005, 3, 238-250.
225. Wang, K.F.; Nagarajan, R.; Camesano, T.A. Antimicrobial peptide alamethicin insertion into lipid bilayer: A qcm-d exploration. Colloid. Surface. B 2014, 116, 472-481.
226. Laver, D.R. The barrel-stave model as applied to alamethicin and its analogs reevaluated. Biophys. J. 1994, 66, 355-359.
227. De Zotti, M.; Biondi, B.; Peggion, C.; Formaggio, F.; Park, Y.; Hahm, K.S.; Toniolo, C. Trichogin ga iv: A versatile template for the synthesis of novel peptaibiotics. Org. Biomol. Chem. 2012, 10, 1285-1299.
228. Yang, L.; Harroun, T.A.; Weiss, T.M.; Ding, L.; Huang, H.W. Barrel-stave model or toroidal model? A case study on melittin pores. Biophys. J. 2001, 81, 1475-1485.
229. Sengupta, D.; Leontiadou, H.; Mark, A.E.; Marrink, S.J. Toroidal pores formed by antimicrobial peptides show significant disorder. Biochim. Biophys. Acta 2008, 1778, 2308-2317.
230. Bechinger, B.; Lohner, K. Detergent-like actions of linear amphipathic cationic antimicrobial peptides. Biochim. Biophys. Acta Biomembr. 2006, 1758, 1529-1539.
231. Bechinger, B. Rationalizing the membrane interactions of cationic amphipathic antimicrobial peptides by their molecular shape. Curr. Opin. Colloid IN 2009, 14, 349-355.
232. Orioni, B.; Bocchinfuso, G.; Kim, J.Y.; Palleschi, A.; Grande, G.; Bobone, S.; Park, Y.; Kim, J.I.; Hahm, K.S.; Stella, L. Membrane perturbation by the antimicrobial peptide pmap-23: A fluorescence and molecular dynamics study. Biochim. Biophys. Acta Biomembr. 2009, 1788, 1523-1533.
233. Pokorny, A.; Birkbeck, T.H.; Almeida, P.F.F. Mechanism and kinetics of delta-lysin interaction with phospholipid vesicles. Biochemistry 2002, 41, 11044-11056.
234. Zhao, H.; Sood, R.; Jutila, A.; Bose, S.; Fimland, G.; Nissen-Meyer, J.; Kinnunen, P.K.J. Interaction of the antimicrobial peptide pheromone plantaricin a with model membranes: Implications for a novel mechanism of action. Biochim. Biophys. Acta Biomembr. 2006, 1758, 1461-1474.
235. Epand, R.M.; Epand, R.F. Bacterial membrane lipids in the action of antimicrobial agents. J. Pept. Sci. 2011, 17, 298-305.
236. Pag, U.; Oedenkoven, M.; Sass, V.; Shai, Y.; Shamova, O.; Antcheva, N.; Tossi, A.; Sahl, H.G. Analysis of in vitro activities and modes of action of synthetic antimicrobial peptides derived from an alpha-helical 'sequence template'. J. Antimicrob. Chemother. 2008, 61, 341-352.
237. Sass, V.; Schneider, T.; Wilmes, M.; Korner, C.; Tossi, A.; Novikova, N.; Shamova, O.; Sahl, H.G. Human beta-defensin 3 inhibits cell wall biosynthesis in staphylococci. Infect. Immun. 2010, 78, 2793-2800.
238. Sass, V.; Pag, U.; Tossi, A.; Bierbaum, G.; Sahl, H.G. Mode of action of human beta-defensin 3 against staphylococcus aureus and transcriptional analysis of responses to defensin challenge. Int. J. Med. Microbiol. 2008, 298, 619-633.
239. Soehnlein, O.; Kai-Larsen, Y.; Frithiof, R.; Sorensen, O.E.; Kenne, E.; Scharffetter-Kochanek, K.; Eriksson, E.E.; Herwald, H.; Agerberth, B.; Lindbom, L. Neutrophil primary granule proteins hbp and hnp1-3 boost bacterial phagocytosis by human and murine macrophages. J. Clin. Investig. 2008, 118, 3491-3502.
240. Funderburg, N.; Lederman, M.M.; Feng, Z.; Drage, M.G.; Jacllowsky, J.; Harding, C.V.; Weinberg, A.; Sieg, S.F. Human beta-defensin-3 activates professional antigen-presenting cells via toll-like receptors 1 and 2. Proc. Natl. Acad. Sci. USA 2007, 104, 18631-18635.
241. Park, C.B.; Kim, M.S.; Kim, S.C. A novel antimicrobial peptide from bufo bufo gargarizans. Biochem. Biophys. Res. Commun. 1996, 218, 408-413.
242. Park, C.B.; Kim, H.S.; Kim, S.C. Mechanism of action of the antimicrobial peptide buforin ii: Buforin ii kills microorganisms by penetrating the cell membrane and inhibiting cellular functions. Biochem. Biophys. Res. Commun. 1998, 244, 253-257.
243. Li, W.F.; Ma, G.X.; Zhou, X.X. Apidaecin-type peptides: Biodiversity, structure-function relationships and mode of action. Peptides 2006, 27, 2350-2359.
244. Gruenheid, S.; Le Moual, H. Resistance to antimicrobial peptides in gram-negative bacteria. FEMS Microbiol. Lett. 2012, 330, 81-89.
245. Belas, R.; Manos, J.; Suvanasuthi, R. Proteus mirabilis zapa metalloprotease degrades a broad spectrum of substrates, including antimicrobial peptides. Infect. Immun. 2004, 72, 5159-5167.
246. Hritonenko, V.; Stathopoulos, C. Omptin proteins: An expanding family of outer membrane proteases in gram-negative enterobacteriaceae. Mol. Membr. Biol. 2007, 24, 395-406.
247. Chromek, M.; Kai-Larsen, Y.; Luthje, P.; Wang, X.; Holm, A.A.; Hedlund, K.O.; Johansson, J.; Chapman, M.R.; Jacobson, S.H.; Romling, U.; et al. The antimicrobial peptide cathelicidin interferes with polymerization of curli fimbrie and thus inhibits the formation of uropathogenic e-coli biofilm. Pediatr. Nephrol. 2010, 25, 1849-1849.
248. Ilg, K.; Endt, K.; Misselwitz, B.; Stecher, B.; Aebi, M.; Hardt, W.D. O-antigen-negative salmonella enterica serovar typhimurium is attenuated in intestinal colonization but elicits colitis in streptomycin-treated mice. Infect. Immun. 2009, 77, 2568-2575.
249. Foschiatti, M.; Cescutti, P.; Tossi, A.; Rizzo, R. Inhibition of cathelicidin activity by bacterial exopolysaccharides. Mol. Microbiol. 2009, 72, 1137-1146.
250. Llobet, E.; Tomas, J.M.; Bengoechea, J.A. Capsule polysaccharide is a bacterial decoy for antimicrobial peptides. Microbiology. 2008, 154, 3877-3886.
251. Campos, M.A.; Vargas, M.A.; Regueiro, V.; Llompart, C.M.; Alberti, S.; Bengoechea, J.A. Capsule polysaccharide mediates bacterial resistance to antimicrobial peptides. Infect. Immun. 2004, 72, 7107-7114.
252. Gunn, J.S. The salmonella pmrab regulon: Lipopolysaccharide modifications, antimicrobial peptide resistance and more. Trends Microbiol. 2008, 16, 284-290.
253. Wang, X.Y.; Ribeiro, A.A.; Guan, Z.Q.; Abraham, S.N.; Raetz, C.R.H. Attenuated virulence of a francisella mutant lacking the lipid a 4'-phosphatase. Proc. Natl. Acad. Sci. USA 2007, 104, 4136-4141.
254. Hein-Kristensen, L.; Franzyk, H.; Holch, A.; Gram, L. Adaptive evolution of escherichia coli to an alpha-peptide/beta-peptoid peptidomimetic induces stable resistance. PloS ONE 2013, 8, e73620.
255. Ernst, R.K.; Guina, T.; Miller, S.I. How intracellular bacteria survive: Surface modifications that promote resistance to host innate immune responses. J. Infect. Dis. 1999, 179, S326-S330.
256. Guo, L.; Lim, K.B.; Gunn, J.S.; Bainbridge, B.; Darveau, R.P.; Hackett, M.; Miller, S.I. Regulation of lipid a modifications by salmonella typhimurium virulence genes phop-phoq. Science 1997, 276, 250-253.
257. Guo, L.; Lim, K.B.; Poduje, C.M.; Daniel, M.; Gunn, J.S.; Hackett, M.; Miller, S.I. Lipid a acylation and bacterial resistance against vertebrate antimicrobial peptides. Cell 1998, 95, 189-198.
258. Nawrocki, K.L.; Crispell, E.K.; McBride, S.M. Antimicrobial peptide resistance mechanisms of gram-positive bacteria. Antibiotics (Basel) 2014, 3, 461-492.
259. Pandit, S.; Cai, J.N.; Song, K.Y.; Jeon, J.G. Identification of anti-biofilm components in withania somnifera and their effect on virulence of streptococcus mutans biofilms. J. Appl. Microbiol. 2015, doi:10.1111/jam.12851.
260. Zhang, Y.; He, L.; Cai, J.; Lv, T.; Yi, Q.; Xu, Y.; Liu, L.; Zhu, J.; Tian, J. Measurements in pediatric patients with cardiomyopathies: Comparison of cardiac magnetic resonance imaging and echocardiography. Cardiology 2015, 131, 245-250.
261. Hu, M.; Zheng, Y.; Cai, J.; Zhang, G.; Li, Q.; Zhou, X.; Wei, Y.; Lu, Y. Cw dual-frequency mopa laser with frequency separation of 45 ghz. Opt. Express 2015, 23, 9881-9889.
262. Dai, D.P.; Geng, P.W.; Cai, J.; Wang, S.H.; Nic, J.J.; Hu, J.H.; Hu, G.X.; Cai, J.P. 293ft is a highly suitable mammalian cell line for the in vitro enzymatic activity analysis of typical p450 proteins. Pharmazie 2015, 70, 33-37.
263. Shafer, W.M.; Qu, X.D.; Waring, A.J.; Lehrer, R.I. Modulation of neisseria gonorrhoeae susceptibility to vertebrate antibacterial peptides due to a, member of the resistance/nodulation/division efflux pump family. Proc. Natl. Acad. Sci. USA 1998, 95, 1829- 1833.
264. Parralopez, C.; Baer, M.T.; Groisman, E.A. Molecular-genetic analysis of a locus required for resistance to antimicrobial peptides in salmonella-typhimurium. EMBO J. 1993, 12, 4053-4062.
265. Chakraborty, K.; Ghosh, S.; Koley, H.; Mukhopadhyay, A.K.; Ramamurthy, T.; Saha, D.R.; Mukhopadhyay, D.; Roychowdhury, S.; Hamabata, T.; Takeda, Y.; et al. Bacterial exotoxins downregulate cathelicidin (hcap-18/ll-37) and human beta-defensin 1 (hbd-1) expression in the intestinal epithelial cells. Cell. Microbiol. 2008, 10, 2520-2537.
266. Arai, T.; Mikami, Y.; Fukushima, K.; Utsumi, T.; Yazawa, K. A new antibiotic, leucinostatin, derived from penicillium lilacinum. J. Antibiot. 1973, 26, 157-161.
267. Nguyen, L.T.; de Boer, L.; Zaat, S.A.; Vogel, H.J. Investigating the cationic side chains of the antimicrobial peptide tritrpticin: Hydrogen bonding properties govern its membrane-disruptive activities. Biochim. Biophys. Acta 2011, 1808, 2297-2303.
268. Grauer, A.; Konig, B. Peptidomimetics - a versatile route to biologically active compounds. Eur. J. Org. Chem. 2009, 5099-5111.
269. Bessalle, R.; Kapitkovsky, A.; Gorea, A.; Shalit, I.; Fridkin, M. All-d-magainin: Chirality, antimicrobial activity and proteolytic resistance. FEBS Lett. 1990, 274, 151-155.
270. Giuliani, A.; Rinaldi, A.C. Beyond natural antimicrobial peptides: Multimeric peptides and other peptidomimetic approaches. Cell. Mol. Life Sci. 2011, 68, 2255-2266.
271. Shalev, D.E.; Rotem, S.; Fish, A.; Mor, A. Consequences of n-acylation on structure and membrane binding properties of dermaseptin derivative k4-s4-(1-13). J. Biol. Chem. 2006, 281, 9432-9438.
272. Giuliani, A.; Pirri, G.; Bozzi, A.; Di Giulio, A.; Aschi, M.; Rinaldi, A.C. Antimicrobial peptides: Natural templates for synthetic membrane-active compounds. Cell. Mol. Life Sci. 2008, 65, 2450-2460.
273. Bionda, N.; Pastar, I.; Davis, S.C.; Cudic, P. In vitro and in vivo activities of novel cyclic lipopeptides against staphylococcal biofilms. Protein pept. Lett. 2014, 21, 352-356.
274. Ahn, M.; Jacob, B.; Gunasekaran, P.; Murugan, R.N.; Ryu, E.K.; Lee, G.H.; Hyun, J.K.; Cheong, C.; Kim, N.H.; Shin, S.Y.; et al. Poly-lysine peptidomimetics having potent antimicrobial activity without hemolytic activity. Amino Acids 2014, 46, 2259-2269.
275. Hansen, T.; Alst, T.; Havelkova, M.; Strom, M.B. Antimicrobial activity of small beta-peptidomimetics based on the pharmacophore model of short cationic antimicrobial peptides. J. Med. Chem. 2010, 53, 595-606.
276. Guo, J.; He, F.; Cai, J.J.; Wang, H.W.; Li, A.F.; Wang, H.G.; Kong, L.R. Molecular and cytological comparisons of chromosomes 7el, 7el, 7e, and 7e derived from thinopyrum. Cytogenet. Genome Res. 2015, 145, 68-74.
277. Wu, C.W.; Sanborn, T.J.; Zuckermann, R.N.; Barron, A.E. Peptoid oligomers with alpha-chiral, aromatic side chains: Effects of chain length on secondary structure. J. Am. Chem. Soc. 2001, 123, 2958-2963.
278. Wu, C.W.; Sanborn, T.J.; Huang, K.; Zuckermann, R.N.; Barron, A.E. Peptoid oligomers with alpha-chiral, aromatic side chains: Sequence requirements for the formation of stable peptoid helices. J. Am. Chem. Soc. 2001, 123, 6778-6784.
279. Sanborn, T.J.; Wu, C.W.; Zuckermann, R.N.; Barron, A.E. Extreme stability of helices formed by water-soluble poly-n-substituted glycines (polypeptoids) with alpha-chiral side chains. Biopolymers 2002, 63, 12-20.
280. Tan, N.C.; Yu, P.; Kwon, Y.U.; Kodadek, T. High-throughput evaluation of relative cell permeability between peptoids and peptides. Bioorg. Med. Chem. 2008, 16, 5853-5861.
281. Bang, J.K.; Nan, Y.H.; Lee, E.K.; Shin, S.Y. A novel trp-rich model antimicrobial peptoid with increased protease stability. Bull. Korean Chem. Soc. 2010, 31, 2509-2513.
282. Chongsiriwatana, N.P.; Patch, J.A.; Czyzewski, A.M.; Dohm, M.T.; Ivankin, A.; Gidalevitz, D.; Zuckermann, R.N.; Barron, A.E. Peptoids that mimic the structure, function, and mechanism of helical antimicrobial peptides. Proc. Natl. Acad. Sci. USA 2008, 105, 2794-2799.
283. Patch, J.A.; Barron, A.E. Helical peptoid mimics of magainin-2 amide. J. Am. Chem. Soc. 2003, 125, 12092-12093.
284. Kapoor, R.; Eimerman, P.R.; Hardy, J.W.; Cirillo, J.D.; Contag, C.H.; Barron, A.E. Efficacy of antimicrobial peptoids against mycobacterium tuberculosis. Antimicrob. Agents Chemother. 2011, 55, 3058-3062.
285. Kapoor, R.; Wadman, M.W.; Dohm, M.T.; Czyzewski, A.M.; Spormann, A.M.; Barron, A.E. Antimicrobial peptoids are effective against pseudomonas aeruginosa biofilms. Antimicrob. Agents Chemother. 2011, 55, 3054-3057.
286. Chongsiriwatana, N.P.; Wetzler, M.; Barron, A.E. Functional synergy between antimicrobial peptoids and peptides against gram-negative bacteria. Antimicrob. Agents Chemother. 2011, 55, 5399-5402.
287. Mojsoska, B., Zuckermann, R.N., Jenssen, H. Structure-activity relationship study of novel peptoids that mimic the structure of antimicrobial peptides. Antimicrob. Agents Chemother. 2015, 59, 4112-4120.
288. Shin, S.B.; Yoo, B.; Todaro, L.J.; Kirshenbaum, K. Cyclic peptoids. J. Am. Chem. Soc. 2007, 129, 3218-3225.
289. Huang, M.L.; Shin, S.B.; Benson, M.A.; Torres, V.J.; Kirshenbaum, K. A comparison of linear and cyclic peptoid oligomers as potent antimicrobial agents. ChemMedChem 2012, 7, 114-122.
290. Huang, M.L.; Benson, M.A.; Shin, S.B.Y.; Torres, V.J.; Kirshenbaum, K. Amphiphilic cyclic peptoids that exhibit antimicrobial activity by disrupting staphylococcus aureus membranes. Eur. J. Org. Chem. 2013, 3560-3566.
291. Gobbo, M.; Benincasa, M.; Bertoloni, G.; Biondi, B.; Dosselli, R.; Papini, E.; Reddi, E.; Rocchi, R.; Tavano, R.; Gennaro, R. Substitution of the arginine/leucine residues in apidaecin ib with peptoid residues: Effect on antimicrobial activity, cellular uptake, and proteolytic degradation. J. Med. Chem. 2009, 52, 5197-5206.
292. Kim, J.K.; Lee, S.A.; Shin, S.; Lee, J.Y.; Jeong, K.W.; Nan, Y.H.; Park, Y.S.; Shin, S.Y.; Kim, Y. Structural flexibility and the positive charges are the key factors in bacterial cell selectivity and membrane penetration of peptoid-substituted analog of piscidin 1. Biochim. Biophys. Acta Biomembr. 2010, 1798, 1913-1925.
293. Liu, Y.; Knapp, K.M.; Yang, L.; Molin, S.; Franzyk, H.; Folkesson, A. High in vitro antimicrobial activity of beta-peptoid-peptide hybrid oligomers against planktonic and biofilm cultures of staphylococcus epidermidis. Int. J. Antimicrob. Agents 2013, 41, 20-27.
294. Olsen, C.A.; Bonke, G.; Vedel, L.; Adsersen, A.; Witt, M.; Franzyk, H.; Jaroszewski, J.W. Alpha-peptide/beta-peptoid chimeras. Org. Lett. 2007, 9, 1549-1552.
295. Olsen, C.A.; Ziegler, H.L.; Nielsen, H.M.; Frimodt-Moller, N.; Jaroszewski, J.W.; Franzyk, H. Antimicrobial, hemolytic, and cytotoxic activities of beta-peptoid-peptide hybrid oligomers: Improved properties compared to natural amps. Chembiochem 2010, 11, 1356-1360.
296. Bonke, G.; Vedel, L.; Witt, M.; Jaroszewski, J.W.; Olsen, C.A.; Franzyk, H. Dimeric building blocks for solid-phase synthesis of alpha-peptide-beta-peptoid chimeras. Synth. Stuttg. 2008, 2381-2390.
297. Ryge, T.S.; Hansen, P.R. Novel lysine-peptoid hybrids with antibacterial properties. J. Pept. Sci. 2005, 11, 727-734.
298. Jahnsen, R.D.; Haney, E.F.; Franzyk, H.; Hancock, R.E. Characterization of a proteolytically stable multifunctional host defense peptidomimetic. Chem. Biol. 2013, 20, 1286-1295.
299. Gottschalk, S.; Ifrah, D.; Lerche, S.; Gottlieb, C.T.; Cohn, M.T.; Hiasa, H.; Hansen, P.R.; Gram, L.; Ingmer, H.; Thomsen, L.E. The antimicrobial lysine-peptoid hybrid lp5 inhibits DNA replication and induces the sos response in staphylococcus aureus. BMC microbiology 2013, 13.
300. Yuan, P.; Di, L.; Zhang, X.; Yan, M.; Wan, D.; Li, L.; Zhang, Y.; Cai, J.; Dai, H.; Zhu, Q.; et al. Efficacy of oral etoposide in pretreated metastatic breast cancer: A multicenter phase 2 study. Medicine 2015, 94, e774.
301. Li, Y.; Smith, C.; Wu, H.; Padhee, S.; Manoj, N.; Cardiello, J.; Qiao, Q.; Cao, C.; Yin, H.; Cai, J. Lipidated cyclic gamma-aapeptides display both antimicrobial and anti-inflammatory activity. ACS Chem. Biol. 2014, 9, 211-217.
302. Chen, X.; Cai, J.; Zhou, X.; Chen, L.; Gong, Y.; Gao, Z.; Zhang, H.; Huang, W.; Zhou, H. Protective effect of spironolactone on endothelial-to-mesenchymal transition in huvecs via notch pathway. Cell. Physiol. Biochem. 2015, 36, 191-200.
303. Zhang, C.; Cui, H.; Cai, J.; Duan, Y.; Liu, Y. Development of fluorescence sensing material based on cdse/zns quantum dots and molecularly imprinted polymer for the detection of carbaryl in rice and chinese cabbage. J. Agric. Food Chem. 2015, 63, 4966-4972.
304. Cherkasov, A.; Jankovic, B. Application of 'inductive' qsar descriptors for quantification of antibacterial activity of cationic polypeptides. Molecules 2004, 9, 1034-1052.
305. Taboureau, O.; Olsen, O.H.; Nielsen, J.D.; Raventos, D.; Mygind, P.H.; Kristensen, H.H. Design of novispirin antimicrobial peptides by quantitative structure-activity relationship. Chem. Biol. Drug Des. 2006, 68, 48-57.
306. Juretic, D.; Vukicevic, D.; Ilic, N.; Antcheva, N.; Tossi, A. Computational design of highly selective antimicrobial peptides. J. Chem. Inf. Model. 2009, 49, 2873-2882.
307. Juretic, D.; Vukicevic, D.; Petrov, D.; Novkovic, M.; Bojovic, V.; Lucic, B.; Ilic, N.; Tossi, A. Knowledge-based computational methods for identifying or designing novel, non-homologous antimicrobial peptides. Eur. Biophys. J. 2011, 40, 371-385.
308. Ilic, N.; Novkovic, M.; Guida, F.; Xhindoli, D.; Benincasa, M.; Tossi, A.; Juretic, D. Selective antimicrobial activity and mode of action of adepantins, glycine-rich peptide antibiotics based on anuran antimicrobial peptide sequences. Biochim. Biophys. Acta 2013, 1828, 1004-1012.
309. Cherkasov, A.; Hilpert, K.; Jenssen, H.; Fjell, C.D.; Waldbrook, M.; Mullaly, S.C.; Volkmer, R.; Hancock, R.E.W. Use of artificial intelligence in the design of small peptide antibiotics effective against a broad spectrum of highly antibiotic-resistant superbugs. ACS Chem. Biol. 2009, 4, 65-74.
310. Fjell, C.D.; Jenssen, H.; Hilpert, K.; Cheung, W.A.; Pante, N.; Hancock, R.E.; Cherkasov, A. Identification of novel antibacterial peptides by chemoinformatics and machine learning. J. Med. Chem. 2009, 52, 2006-2015.
311. Fjell, C.D.; Jenssen, H.; Cheung, W.A.; Hancock, R.E.; Cherkasov, A. Optimization of antibacterial peptides by genetic algorithms and cheminformatics. Chem. Biol. Drug Des. 2011, 77, 48-56.